Robin A. van der Meulen is a Partner in the New York office of Labaton Sucharow LLP, where she represents clients in complex antitrust litigation. Robin has over a decade of experience litigating a wide variety of antitrust matters, including price-fixing, monopolization, benchmark and commodities manipulation, pay-for-delay agreements, and other anti-competitive practices.
The Legal 500 recommends Robin for excellence in the field of Antitrust Civil Litigation and Class Actions, describing her as "persistent, persuasive, and well-respected by peers and opponents alike" and naming her a "Next Generation Partner." She has been recognized as "Up and Coming" by Chambers & Partners USA and as a "Future Star" by Benchmark Litigation. She has also been selected to Benchmark's "40 & Under Hot List" as one of “the best and brightest law firm partners" and someone who is "ready to take the reins."
Robin was recently appointed to lead a class of end-payor plaintiffs in In re Bystolic Antitrust Litigation, a pay-for-delay case pending in the Southern District of New York. Robin is also currently representing end-payor plaintiffs in In re Generic Pharmaceuticals Pricing Antitrust Litigation, a massive case against some of the biggest drug companies in the world alleging price-fixing and anticompetitive conspiracies. Robin is leading another pay-for-delay case, In re Novartis and Par Antitrust Litigation, seeking to recover millions of dollars in overcharges relating to hypertension drug Exforge on behalf of end-payor plaintiffs.
Prior to joining Labaton Sucharow, Robin was a Litigation Associate at Willkie Farr & Gallagher LLP, where she practiced antitrust and commercial litigation. She also served as a Judicial Intern in the United States Bankruptcy Court for the Eastern District of New York for the Honorable Elizabeth S. Stong.
Robin is an active member of the antitrust bar. She is a member of the Executive Committee of the Antitrust Law Section of the New York State Bar Association (NYSBA) and a member of NYSBA House of Delegates. Robin is also a Vice Chair of the Antitrust Section’s Health Care & Pharmaceutical Committee of the American Bar Association and the Executive Editor of that Committee’s Antitrust Health Care Chronicle. Since 2012, Robin has been an editor of the Health Care Antitrust Week-In-Review, a weekly publication that summarizes antitrust news in the health care industry.
Robin earned her Juris Doctor from Brooklyn Law School. While in law school, Robin served as an Associate Managing Editor of the Journal of Law and Policy and was a member of the Moot Court Honor Society. She earned her Bachelor of Arts from Columbia University where she competed as a Division I athlete on Columbia’s track and field team.
2010, New York
U.S. Court of Appeals
2011, Second Circuit
U.S. District Court
2010, Southern District of New York
2010, Eastern District of New York